RN Mobile Menu

Search form


Rheumatology Network

Safety of NSAIDs for Arthritic Pain Examined in Clinical Trial

PRECISION trial shows that naproxen is not associated with superior cardiovascular safety as compared to celecoxib.
(©Sebastian Kaulitzki/Shutterstock.com)


Recent Content

Up to 30% of psoriasis patients will develop psoriatic arthritis. Studies show that a proportion of patients in clinical care have undiagnosed PsA.

TNF-α inhibitor treatment in PsA, RA and AS may be associated with a significant increase in total cholesterol, triglyceridesand the atherogenic index. Statins with treatment lowered LDL levels.

Women heart disease (©TheerapolPongkangsananan;Shutterstock.com); Pain Managemen

The long-awaited results from the PRECISION trial are in — with some caveats. In this slideshow, we summarize the results.


Rheumatoid arthritis patients run an increased risk of malignant cancers, independent of biologic and DMARD treatment, researchers report.

For rheumatoid arthritis patients who cannot tolerate methotrexate, combination therapy isn't often an option. This study offers a new approach for these patients.

Researchers reporting at the American Society of Hematology annual meeting this week say there is a link between a treatment for autoimmune disease and the development of leukemia.

Women who have rheumatoid arthritis might benefit from treatment with denosumab over alendronate. According to a new study, denosumab is more effective at bone healing.

By clicking Accept, you agree to become a member of the UBM Medica Community.